Carnegie Mellon University leads a multi-institutional collaboration awarded $26.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop next-generation at-home cancer screening technology. This innovative platform aims to detect over 30 cancers through minimally invasive, accessible methods, facilitating early diagnosis and improved patient outcomes. By enabling widespread population screening outside clinical settings, the initiative has the potential to transform cancer detection paradigms and reduce disease burden.